Menu
Back to Journals » International Journal of General Medicine » Volume 2
Development of a vaccine to prevent Japanese encephalitis: a brief review
Authors Wiwanitkit V
Published 15 October 2009 Volume 2009:2 Pages 195—200
DOI https://doi.org/10.2147/IJGM.S6281
Review by Single anonymous peer review
Peer reviewer comments 4
Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok, Thailand
Abstract: Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper management to deal with this virus is essential. There is no specific treatment for Japanese encephalitis virus. Supportive and symptomatic treatments are usually used, which emphasize the importance of prevention in this specific neurological disorder. Vector control or vaccination can be used to prevent the disease. Because the existing Japanese encephalitis vaccine poses some undesirable problems, a new vaccine is needed. The process of developing a new vaccine is briefly discussed.
Keywords: Japanese encephalitis, vaccine, concept, prevention, development
© 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.